IBN SINA’s EPS up by 11.74% in Q2

The IBN SINA Pharmaceutical Industry Ltd reported its earnings per share increased by 11.74 percent in the second quarter (October-December) last year.

Its consolidated EPS was Tk4.95 in Q2 last year, up from Tk4.43 recorded in the same period a year earlier, said the company in a filing with the Dhaka Stock Exchange.

In the final six months of 2020, the EPS of the company was Tk8.19, which was Tk7.30 in the previous year’s corresponding period.

The consolidated net operating cash flow per share (NOCFPS) was Tk10.48 for July-December 2020 against Tk3.69 for the same period of 2019.